Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Lifecore Biomedical, Inc.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Lifecore Biomedical (LFCR), Elanco Animal Health (...

Analysts Offer Insights on Healthcare Companies: Lifecore Biomedical (LFCR), Elanco Animal Health (ELAN) and Alpha Teknova (TKNO)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Palvella Therapeutics (PVLA) and Lifecore Biomedical...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	LFCR	$4.54	0.00%	132.04K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	LFCR	$4.54	0%	132.04K
3
4
5
6

LFCR

Get Lifecore Biomedical, Inc. Data in Excel

Get Lifecore Biomedical, Inc. Data in Excel